abdullah's picture
Add files using upload-large-folder tool
cee63d3 verified
raw
history blame
28.9 kB
1
00:00:01,670 --> 00:00:06,830
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ู†ู„ุชู‚ูŠ
2
00:00:06,830 --> 00:00:11,530
ุงู„ูŠูˆู… ุฃูŠุถุง ููŠ ู…ุญุงุถุฑุฉ ุจุนู†ูˆุงู† the non-leukemic
3
00:00:11,530 --> 00:00:20,070
malignant disorders by definition non-leukemic
4
00:00:20,070 --> 00:00:25,520
malignant disorders ุจุดูƒู„ ุฃุณุงุณูŠ ุจุฃู†ู‡ู… ู…ุฌู…ูˆุนุงุช ู…ูˆุฑููˆุณ
5
00:00:25,520 --> 00:00:30,080
ูˆู„ูŠู†ุงู„ ุฏูŠุณ ุฃูˆุฑุฏุงุฒ ูŠุชู…ูŠุฒูˆุง ุจู€ uncontrolled clonal
6
00:00:30,080 --> 00:00:33,400
proliferation of bone marrow ุฏู„ูˆู‚ุชู ุฃูŠ ุฎู„ูŠุฉ ู…ู†
7
00:00:33,400 --> 00:00:39,020
ุฎู„ุงูŠุง ุงู„ู€ bone marrow blood cellular ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ู€ bone
8
00:00:39,020 --> 00:00:41,560
marrow ุจุชุณู„ู‘ู‡ุง abnormal clonal proliferation
9
00:00:41,560 --> 00:00:46,200
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุฒูŠุฏ ุนุฏุฏู‡ุง ุฒูŠุงุฏุฉ ู…ู‡ูˆู„ุฉ Classification
10
00:00:46,200 --> 00:00:50,350
ู‚ุณู…ูˆู‡ุง ุฅู„ู‰ ู†ูˆุนูŠู†ุŒ ุฃูˆู„ู‡ุง ุงู„ู€ proliferative
11
00:00:50,350 --> 00:00:54,130
disorders ูˆู‡ุฐู‡ ุชุดู…ู„ primary proliferative
12
00:00:54,130 --> 00:00:58,590
polycythemia ูˆ primary thrombocythemia ูˆ
13
00:00:58,590 --> 00:01:01,070
myelofibrosis ูˆู†ุญู† ุณู†ุชุทุฑู‚ ุฅู„ูŠู‡ู… ุฅู† ุดุงุก ุงู„ู„ู‡
14
00:01:01,070 --> 00:01:04,510
ุจุงู„ุชูุตูŠู„ุŒ ุซู… ุงู„ู†ูˆุน ุงู„ุซุงู†ูŠ ุงู„ู€ proliferative
15
00:01:04,510 --> 00:01:11,330
disorders ูˆุงุฎุชุฑู†ุง ู„ูƒู… multiple myeloma and
16
00:01:11,330 --> 00:01:15,130
related plasma cell disorders ุซู… Hodgkin disease ูˆ
17
00:01:15,130 --> 00:01:16,190
non Hodgkin lymphoma
18
00:01:18,750 --> 00:01:22,890
ูˆู†ุจุฏุฃ ุจุงู„ู€ Myeloproliferative non-leukemic
19
00:01:22,890 --> 00:01:27,770
myeloproliferative disorders ูˆุงุชูู‚ู†ุง ุนู„ู‰ ุฃู† ู‡ุฐุง
20
00:01:27,770 --> 00:01:32,390
ุนุจุงุฑุฉ ุนู† hematopoietic stem cell disorders ุฃู†ู‡ ูƒู„ูˆู†ุงู„
21
00:01:32,390 --> 00:01:36,810
ูˆูŠุชู…ูŠุฒ ุจูˆุฌูˆุฏ granulocytic ูˆ erythrocytic ูˆ
22
00:01:36,810 --> 00:01:45,110
megakaryocytic increase ุซู„ุงุซุฉ ุจูŠุตูŠุฑ ู„ู‡ู… abnormal
23
00:01:45,110 --> 00:01:49,100
clonal proliferation ู…ูˆุฌูˆุฏ ู‡ูˆ ุฃู†ู‡ ููŠู‡ inter
24
00:01:49,100 --> 00:01:54,960
relation between this increase and their diseases
25
00:01:54,960 --> 00:02:00,540
ูุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ RBCs ุจูŠุณู…ูˆู‡ุง polycythemia
26
00:02:00,540 --> 00:02:04,740
platelet ุจูŠุณู…ูˆู‡ุง essential thrombocythemia ุซู… ุงู„ู€
27
00:02:04,740 --> 00:02:11,980
myelofibrosis ู‡ูˆ ุนุจุงุฑุฉ ุนู† fibrosis ู†ุชูŠุฌุฉ ุงู„ู€ mega
28
00:02:11,980 --> 00:02:16,350
karyocytic abnormal clonal proliferation of
29
00:02:16,350 --> 00:02:22,390
megakaryocytic proliferation
30
00:02:22,390 --> 00:02:27,970
ุทุจุนุง ู‡ูŠ ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† ู‡ูŠ ุนุจุงุฑุฉ ุนู† ุงู„ู€ stepwise
31
00:02:27,970 --> 00:02:32,290
ุงู„ู€ progression of to fibrosis to marrow failure or
32
00:02:32,290 --> 00:02:35,590
acute blast phase ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† ู‡ูŠ ุงู„ู€ bone
33
00:02:35,590 --> 00:02:41,750
marrow stem cell ุงูƒุชุณุจุช mutation ุงู„ู€ abnormal ูˆ
34
00:02:41,750 --> 00:02:47,550
acquired abnormality ูุงู„ุชุฃุซูŠุฑ ุทุจุนุง ู„ู€ granulocytic ูˆุงู„ู€
35
00:02:47,550 --> 00:02:50,810
RBCs ูˆุงู„ู€ megakaryocytic ู„ุฃู†ู†ุง ู†ุญูƒูŠ ุนู„ู‰
36
00:02:50,810 --> 00:02:55,650
myeloproliferase granulocytic ู„ู…ุง ุตุงุฑ ู„ู‡ ูƒู„ูˆู†ุงู„ ุงู„ู€
37
00:02:55,650 --> 00:03:01,710
proliferation ุฃุฏุชู†ุง chronic myeloid leukemia ูˆ ุงู„ู€
38
00:03:01,710 --> 00:03:08,860
RBCs precursor ุฃุฏู‰ ู„ู€ polycythemia ุฃูˆ Polycythemia vera ูˆุงู„ู€
39
00:03:08,860 --> 00:03:12,940
Megakaryocytes is the essential thrombocythemia
40
00:03:12,940 --> 00:03:18,640
which can transform to reactive fibrosis ูˆุจุชูƒูˆู†
41
00:03:18,640 --> 00:03:24,400
ู‡ูŠ ุงู„ู€ myelofibrosis ูˆู„ุงุญุธูˆุง ุงู„ุนู„ุงู‚ุฉ ู…ุง ุจูŠู† ู‡ุฐู‡
42
00:03:24,400 --> 00:03:29,310
ุงู„ุฃู…ุฑุงุถ ูˆู…ุง ุจูŠู† ุงู„ู€ acute myeloid leukemia ูุฌุงู„ูˆุง ุฃู†
43
00:03:29,310 --> 00:03:33,030
ุงู„ู€ chronic myeloid leukemia 70% ู…ู†ู‡ุง ุจูŠุฌู„ุจ ู„ู€ acute
44
00:03:33,030 --> 00:03:37,610
myeloid leukemia polycythemia 10% ู…ู†ู‡ุง ุจูŠุฌู„ุจ ู„ู€
45
00:03:37,610 --> 00:03:41,190
acute myeloid leukemia essential thrombocythemia
46
00:03:41,190 --> 00:03:47,890
sorry polycythemia ุฃูŠุถุง ู…ู…ูƒู† ุชุชุญูˆู„ ู„ู€ myelofibrosis
47
00:03:47,890 --> 00:03:53,370
30% ู…ู†ู‡ุง ูˆ ุงู„ู€ myelofibrosis ู…ู…ูƒู† 10% ู…ู†ู‡ ูŠุตูŠุฑ
48
00:03:53,370 --> 00:04:00,060
acute myeloid leukemia ูููŠ interrelation between
49
00:04:00,060 --> 00:04:07,020
these disorders ู†ุจุฏุฃ ุจุฃูˆู„ ู‡ุฐู‡ ุงู„ุฃู†ูˆุงุน ุงู„ู€ primary
50
00:04:07,020 --> 00:04:11,810
proliferative polycythemia ุงู„ุชูŠ ุชุณู…ู‰ Malignant
51
00:04:11,810 --> 00:04:15,710
disorders ูˆููŠู‡ุง ุจูŠูˆุชูƒุณ ุชู…ุซู„ And it's
52
00:04:15,710 --> 00:04:18,550
characterized by absolute erythrocytosis ูŠุจู‚ู‰
53
00:04:18,550 --> 00:04:23,390
ุจู…ุงุฐุง ูŠุชู…ูŠุฒุŸ ูŠุชู…ูŠุฒ by absolute erythrocytosis
54
00:04:23,390 --> 00:04:27,390
ูˆุทุจุนุง ู„ุฃู† ุงู„ุฃุตู„ ูˆุงุญุฏ ูุจูŠุตูŠุฑ ููŠ ุฒูŠุงุฏุฉ ุงู„ู€ increase
55
00:04:27,390 --> 00:04:34,070
ู„ู€ granulocyte ูˆ ุงู„ู€ count ูˆ ุงู„ู€ platelet ู…ู…ูƒู† ุชูŠุฌูŠ ู„ู„ุฅู†ุณุงู†
56
00:04:34,070 --> 00:04:42,500
ููŠ ุฃูŠ ุนู…ุฑุŒ ุงู„ุฎุทูˆุฑุฉ ู‡ูŠ ุนู…ุฑ ุงู„ุดุจุงุจ ููŠ people ุนู…ุฑ
57
00:04:42,500 --> 00:04:48,440
ุงู„ุดุจุงุจ ููŠ people ู‡ูˆ ุญูˆุงู„ูŠ 55 ุณู†ุฉุŒ ุงู„ู€ adults ูŠุชุฃุซุฑูˆู†
58
00:04:48,440 --> 00:04:51,620
ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ
59
00:04:51,620 --> 00:04:54,820
ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจ
60
00:04:54,820 --> 00:04:55,060
ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ
61
00:04:55,060 --> 00:04:55,360
ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจ
62
00:04:55,360 --> 00:04:56,140
ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ
63
00:04:56,140 --> 00:04:56,960
ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจุŒ ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจ
64
00:04:56,960 --> 00:05:07,190
ุจุดูƒู„ ุฃูƒุซุฑ ู…ู† ุงู„ุดุจุงุจ ุงู„ุชูŠ ุชุชุนุงู…ู„ ุจุดูƒู„ autonomous ููŠ ุงู„ู€
65
00:05:07,190 --> 00:05:10,510
abnormal decline ุงู„ู€
66
00:05:10,510 --> 00:05:15,910
disease phases ู‚ุงู„ูˆุง ููŠู‡ ุซู„ุงุซุฉ phases ุบุงู„ุจุง
67
00:05:15,910 --> 00:05:21,030
proliferative phase ุซู… spent ุฃูˆ post polycythemic
68
00:05:21,030 --> 00:05:26,090
phase ูˆู‚ู„ู†ุง rarely transformed into acute leukemia
69
00:05:26,090 --> 00:05:27,150
ูู‡ุฐุง phase ุซุงู„ุซ
70
00:05:30,380 --> 00:05:34,420
recognition of polycythemia ู‚ุงู„ูˆุง ุงู„ู€ recognition
71
00:05:34,420 --> 00:05:37,940
by measuring ุงู„ู€ red cell volume ุฃูˆ ุงู„ู€ hematocrit
72
00:05:37,940 --> 00:05:41,540
ูˆุฌุฏูˆุง ุฃู† ุงู„ู€ male ุงู„ู…ูุฑูˆุถ ูŠูƒูˆู† ุฃูƒุซุฑ ู…ู† ูˆุงุญุฏ ูˆุฎู…ุณูŠู†
73
00:05:41,540 --> 00:05:51,140
ูˆ ุงู„ู€ female ุฃูƒุซุฑ ู…ู† ุซู…ุงู†ูŠุฉ ูˆุฑุจุนูŠู† ูˆุงู„ุชุบูŠุฑ
74
00:05:51,140 --> 00:05:56,060
ููŠ ุงู„ู€ RBC ู…ู…ูƒู† ูŠูƒูˆู† ู„ู‡ ุณุจุจ ุขุฎุฑ ูˆู‡ูˆ ุงู„ู€ reduction in
75
00:05:56,060 --> 00:06:04,340
plasma ุฃูˆ true increase in RBCs number ูŠุจู‚ู‰ ู‡ุฐู‡
76
00:06:04,340 --> 00:06:11,680
ุฃุณุจุงุจ ุงู„ู€ polycythemia Classification ู‚ุณู…ูˆู‡ุง ู„ู†ูˆุนูŠู†
77
00:06:11,680 --> 00:06:16,640
ุฃุณุงุณูŠูŠู†ุŒ ุฃูˆู„ู‡ู…ุง ุงู„ู€ absolute ุฃูˆ ุจูŠุณู…ู‰ true ูˆุงู„ู€ true
78
00:06:16,640 --> 00:06:21,370
ุจุชุดู…ู„ primary proliferative polycythemia ุงู„ู„ูŠ ู†ุญู†
79
00:06:21,370 --> 00:06:24,830
ุชุงูˆู„ู†ุง ุญูƒูŠู†ุง ุนู†ู‡ุง ุซู… secondary polycythemia
80
00:06:24,830 --> 00:06:29,730
ูˆ idiopathic erythrocytosis for unknown reason
81
00:06:29,730 --> 00:06:34,150
ุจุชู„ุงู‚ูŠ ุงู„ู€ RBC's ุนุงู„ูŠุฉุŒ ู†ูˆุน ุงู„ุซุงู†ูŠ ู…ู† ุงู„ู€
82
00:06:34,150 --> 00:06:37,770
polycythemia ู‡ูˆ ุงู„ู€ apparent or relative ูˆู‡ุฐู‡
83
00:06:37,770 --> 00:06:45,870
ู†ุชูŠุฌุงุช ุงู„ู€ plasma volume ุฃูˆ RBC's mass changes ู†ุฑุฌุน
84
00:06:45,870 --> 00:06:49,690
ู„ู„ู€
85
00:06:53,560 --> 00:06:58,280
absolute ู„ุฃุณุจุงุจ ุงู„ู€ absolute polycythemia ู‚ุงู„ูˆุง
86
00:06:58,280 --> 00:07:02,000
ุงู„ู€ malignant transformation ุจูŠุฎู„ูŠ ุงู„ู€ hemopoietic
87
00:07:02,000 --> 00:07:06,060
stem cell to be free from hormonal control
88
00:07:06,060 --> 00:07:09,080
ูˆุจุงู„ุชุงู„ูŠ
89
00:07:09,080 --> 00:07:13,640
ู„ุง ุชุชุฃุซุฑ ุจุชุบูŠุฑ ุงู„ู‡ุฑู…ูˆู† ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ erythropoietin ู‡ุฑู…ูˆู†
90
00:07:13,640 --> 00:07:16,680
ุนุดุงู† ู‡ูŠูƒ ุงู„ู€ erythropoietin ู‡ุฑู…ูˆู† is decreased ููŠ ู‡ุฐู‡
91
00:07:16,680 --> 00:07:21,920
ุงู„ุญุงู„ุงุช hypoxic effect has no effect
92
00:07:26,580 --> 00:07:31,220
ููŠุฒูŠูˆู„ูˆุฌูŠุง ู…ู…ูƒู† ุฃู† ูŠูƒูˆู† ู‡ู†ุงูƒ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ
93
00:07:31,220 --> 00:07:31,700
ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
94
00:07:31,700 --> 00:07:33,000
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
95
00:07:33,000 --> 00:07:34,620
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
96
00:07:34,620 --> 00:07:35,400
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
97
00:07:35,400 --> 00:07:37,940
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
98
00:07:37,940 --> 00:07:39,420
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
99
00:07:39,420 --> 00:07:40,900
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
100
00:07:40,900 --> 00:07:44,740
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุฃูˆ
101
00:07:44,740 --> 00:07:52,400
stimuli ุบูŠุฑ ู…ู†ุงุณุจุฉ ุงู„ู„ูŠ abnormal ุงู„ู€ primary
102
00:07:52,400 --> 00:07:56,480
proliferative polycythemia and this is a malignant
103
00:07:56,480 --> 00:08:05,900
disorder ู„ูƒู† ูู‡ู… ุฃู†ูˆุงุน ุงู„ู€ polycythemia ุจุงู„ูƒุงู…ู„
104
00:08:05,900 --> 00:08:10,760
ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุถุฑูˆุฑุฉ ู„ุฃู† ุงู„ู€ recognition of primary
105
00:08:10,760 --> 00:08:15,400
progressive polycythemia is based on exclusion
106
00:08:29,780 --> 00:08:38,120
ุจูŠู†ู„ูŠ ุงู„ู€ classification of polycythemia ุฃูŠ
107
00:08:38,120 --> 00:08:43,940
polycythemia vera ุฃูˆ ุงู„ู€ PCV ุชูƒูˆู† ุนุงู„ูŠุฉ ุงุณู…ู‡ุง ุงู„ู€
108
00:08:43,940 --> 00:08:48,920
absolute ุฃูˆ ุจูŠุณู…ูˆู‡ true ูˆุฃู† ู‡ุฐุง ุจูŠุญุชูˆูŠ ุนู„ู‰ ู†ูˆุนูŠู†
109
00:08:48,920 --> 00:08:53,200
ู†ูˆุน ุงู„ุฃูˆู„ุงู†ูŠ ุจูŠุณู…ูˆู‡ primary ูˆุงู„ู€ erythropoietin ููŠู‡
110
00:08:53,200 --> 00:08:59,220
ุจูŠูƒูˆู† decreased ูˆู†ูˆุน ุงู„ุซุงู†ูŠ ู‡ูˆ ุงู„ู€ secondary
111
00:08:59,220 --> 00:09:03,460
ูˆุงู„ู€ erythropoietin ููŠู‡ ุจูŠูƒูˆู† ุนุงู„ูŠ ุจุงู„ู†ุณุจุฉ ู„ู„ู€ secondary
112
00:09:03,460 --> 00:09:06,660
ุงู„ู„ูŠ ุจูŠุจู‚ู‰ ุงู„ู€ erythropoietin ููŠู‡ ุนุงู„ูŠ ุฒูŠุงุฏุฉ
113
00:09:06,660 --> 00:09:09,340
ุงู„ู€ erythropoietin ู…ู…ูƒู† ุชูƒูˆู† due to appropriate cause
114
00:09:09,340 --> 00:09:12,700
or inappropriate cause ูุงู„ู€ appropriate cause ุฒูŠ ุงู„ู€
115
00:09:12,700 --> 00:09:18,510
altitude ู‡ุฐุง ูˆุงุถุญ ุทุจูŠุนูŠุŒ ุฒูŠ ุงู„ู€ Cardiopulmonary ุจุฑุถู‡
116
00:09:18,510 --> 00:09:22,790
ูˆุฏู‡ ุทุจูŠุนูŠ ุฒูŠ ุงู„ู€ smoking ุจูŠุคุฏูŠ ุฅู„ู‰ ุฒูŠุงุฏุฉ
117
00:09:22,790 --> 00:09:26,150
ุงู„ู€ erythropoietin ูˆู„ู…ุง appropriate ูˆุฌูˆุฏ cancer ุฃูˆ
118
00:09:26,150 --> 00:09:31,810
tumor ุฃูˆ even cyst ุจุนูŠุฏุฉ ุนู† ุงู„ุฃุณูˆุฃ ุฅู† ูƒุงู† ููŠ ุงู„ู€ kidney
119
00:09:31,810 --> 00:09:38,330
ูˆู„ุง ุฒูŠ renal ูˆู„ุง extra renal tumor ู‡ุฐุง ุจูŠุญูุธ ุนู„ู‰
120
00:09:38,330 --> 00:09:43,110
ุฅู†ุชุงุฌ ุงู„ู€ erythropoietin ุฃู…ุง ุงู„ุซุงู†ูŠ ู…ู† ุงู„ู€ polycythemia
121
00:09:43,110 --> 00:09:45,630
ู‡ูˆ ุงู„ู€ apparent ุงู„ู„ูŠ ูŠูƒูˆู† ููŠ ุงู„ู€ red cell mass
122
00:09:45,630 --> 00:09:49,450
could be normal ู„ูƒู† due to hydration or stress or
123
00:09:49,450 --> 00:09:54,630
smoking ุจูŠุจุฏุฃ ูŠุญุตู„ ููŠู‡ ุฒูŠุงุฏุฉ ู†ุณุจูŠุฉ ู„ู„ู€ RBCs mass
124
00:09:54,630 --> 00:10:03,010
ุจุงู„ู†ุณุจุฉ ู„ู„ู€ plasma secondary polycythemia usually
125
00:10:03,010 --> 00:10:10,260
due to known causes ูˆู‚ุงู„ูˆุง ููŠู‡ ู…ู†ู‡ ู†ูˆุนูŠู† ูƒู…ุจู†ุณุงุชูˆุฑูŠ
126
00:10:10,260 --> 00:10:14,440
increase ููŠ ุงู„ู€ erythropoietin ุฃูˆ appropriate release of
127
00:10:14,440 --> 00:10:17,640
erythropoietin ุฒูŠ ููŠ ุญุงู„ุฉ ุงู„ู€ high altitude
128
00:10:17,640 --> 00:10:21,280
pulmonary disease heart disease ุฒูŠ ุงู„ู€ cyanotic
129
00:10:21,280 --> 00:10:24,460
heart disease abnormal hemoglobin high affinity
130
00:10:24,460 --> 00:10:28,060
hemoglobin heavy cigarette smokers ูƒู„ ู‡ุฐู‡ ุนุจุงุฑุฉ ุนู†
131
00:10:28,060 --> 00:10:31,620
ุฃุณุจุงุจ ูˆุญุงู„ุงุช ู…ุฑุถูŠุฉ ุจูŠุตูŠุฑ ููŠู‡ุง appropriate ุฃูˆ
132
00:10:31,620 --> 00:10:36,190
compensatory increase in erythropoietin ุงู„ู†ูˆุน ุงู„ุซุงู†ูŠ
133
00:10:36,190 --> 00:10:39,310
ุงู„ู„ูŠ ู‡ูˆ inappropriate erythropoietin production ูŠูˆู…
134
00:10:39,310 --> 00:10:43,530
ุฒูŠ ู…ุง ู‚ู„ู†ุง ูŠูƒูˆู† ููŠู‡ tumor ุณูˆุงุก ูƒุงู† renal ูˆู„ุง
135
00:10:43,530 --> 00:10:50,490
ููŠุจุฑูˆู…ูŠูˆู†ุฉ ู…ูˆุฌูˆุฏุฉ ููŠ extra-renal ุฃูˆ hydronephrosis
136
00:10:50,490 --> 00:10:54,730
ููŠ ุงู„ู€ renal ูˆ liver carcinoma extra-renal ูˆู‡ูƒุฐุง
137
00:10:54,730 --> 00:11:00,970
ุฏูˆู„ ูƒู„ู‡ู… ุนุจุงุฑุฉ ุนู† cancers ุจูŠุคุฏูˆุง ุจูŠุญูุธูˆุง ุนู„ู‰ ุชุตู†ูŠุน
138
00:11:00,970 --> 00:11:06,050
ุงู„ู€ erythropoietin ุจุณ ุฏูˆู† ุงู„ุญุงุฌุฉ ู„ู‡ุŒ ูˆุจุงู„ุชุงู„ูŠ ูŠุฒูŠุฏ
139
00:11:06,050 --> 00:11:11,530
ุงู„ู€ erythropoietin ู†ุณุจูŠุงู‹ Caused physiological
140
00:11:11,530 --> 00:11:14,410
appropriate release of erythropoietin
141
00:11:14,410 --> 00:11:17,170
ูˆPhysiologically inappropriate release of
142
00:11:17,170 --> 00:11:21,970
erythropoietin ุงู„ููŠุฒูŠูˆู„ูˆุฌูŠูƒูŠ ุฅุชุฑุงุจูุช ุฅูŠู‡ ุฑูŠู„ูŠุฒ
143
00:11:21,970 --> 00:11:27,570
ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ูŠุนู†ูŠ ุฃุณุจุงุจู‡ุง ูƒุงู„ุนุงุฏุฉ ุงู„ุณุจุจ ุงู„ุฃูˆู„ุงู†ูŠ
144
00:11:27,570 --> 00:11:30,170
ุฃู† ูŠูƒูˆู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ู…ุณุชู…ุฑูŠู† ููŠ ุงู†ุฎูุงุถ ุงู„ุฃูƒุณุฌูŠู†
145
00:11:30,170 --> 00:11:33,790
ุชู†ุดุฆ ุฃู†ุช ุฌุงู„ุณ ููŠ ู…ูƒุงู† ู…ุง ููŠู‡ ุงูƒุณุฌูŠู† ุฒูŠ ู…ุง ูŠุญุตู„
146
00:11:33,790 --> 00:11:39,490
ููŠ ุงู„ู€ high altitude ุงู„ุณุจุจ ุงู„ุซุงู†ูŠ ู‡ูˆ inadequate
147
00:11:39,490 --> 00:11:44,770
uptake of atmospheric oxygen ููŠู‡ ุฃูƒุณุฌูŠู† ุจุณ ุฃู†ุช
148
00:11:44,770 --> 00:11:48,690
ู…ุงุจุชุงุฎุฐู‡ ุจุงู„ูƒู…ูŠุงุช ุงู„ูƒุงููŠุฉ ุฒูŠ ุงู„ู€ chronic
149
00:11:48,690 --> 00:11:52,170
bronchitis ุฃูˆ ุงู„ููŠุฒูŠุงู…ุง ุจู„ู…ูˆู†ุงุฑูŠ ููŠุจุฑูˆุณูŠุฒ
150
00:11:52,170 --> 00:11:56,750
ุจู„ู…ูˆู†ุงุฑูŠ ุฅูŠุฏู…ุง ู‡ุฐุง ุณุจุจ ุดุงุฆุน ุงู„ููƒุฑุฉ ูƒุซูŠุฑ ูŠุจู‚ู‰ ุงู„ุฃูˆู„ุงู†ูŠ
151
00:11:56,750 --> 00:11:59,410
ุฃู† ุฃู†ุช ุฌุงู„ุณ ููŠ ุฌูˆ ู…ุง ููŠู‡ ุฃูƒุณุฌูŠู† ุงู„ุซุงู†ูŠ ููŠู‡
152
00:11:59,410 --> 00:12:05,420
ุฃูƒุณุฌูŠู† ู„ูƒู† ู…ุง ุจุชุนุฑู ุชุงุฎุฏู‡ ุฃูˆ ุชุงุฎุฏู‡ inadequately ุณุจุจ
153
00:12:05,420 --> 00:12:11,480
ุซุงู„ุซ ุฃู†ู‡ ููŠ ุฃูƒุณูˆุฌูŠู† ุฃู†ุช ุฌุงู„ุณ ููŠ ุฌูˆ ููŠู‡ ุฃูƒุณูˆุฌูŠู† ูˆ
154
00:12:11,480 --> 00:12:16,920
ุจุชุงุฎุฏ ุงู„ุฃูƒุณูˆุฌูŠู† appropriately ุฃูˆ adequately ู„ูƒู†
155
00:12:16,920 --> 00:12:19,660
ุจูŠุตูŠุฑ ููŠู‡ defect ููŠ ุงู„ู€ transport of absorbed
156
00:12:19,660 --> 00:12:25,080
oxygen from the lung ูˆู‡ุฐุง ู…ู…ูƒู† ูŠุตูŠุฑ ููŠ variety of
157
00:12:25,080 --> 00:12:28,400
inherited or acquired defect of hemoglobin
158
00:12:28,400 --> 00:12:33,460
function ุงู„ู…ุดูƒู„ุฉ ุงู„ุฃูŠุถูŠุฉ ุงู„ุชูŠ ุชู‚ู„ู„ ุฅุฏุงุฑุฉ
159
00:12:33,460 --> 00:12:36,940
ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ
160
00:12:36,940 --> 00:12:39,140
ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ
161
00:12:39,140 --> 00:12:39,560
ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ
162
00:12:39,560 --> 00:12:40,340
ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ
163
00:12:40,340 --> 00:12:42,480
ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ
164
00:12:42,480 --> 00:12:44,720
ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ
165
00:12:44,720 --> 00:12:47,360
ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ
166
00:12:47,360 --> 00:12:51,140
ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ
167
00:12:51,140 --> 00:12:57,700
ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงุฌ ุฅู„ู‰ ุฅุฏุงุฑุฉ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู† ุชุญุชุงู„ู€
168
00:12:57,700 --> 00:12:59,800
Physiologically Inappropriate Release of
169
00:12:59,800 --> 00:13:04,380
erythropoietin ููŠู‡ variety of disorders associated
170
00:13:04,380 --> 00:13:06,640
with inappropriate release of erythropoietin
171
00:13:06,640 --> 00:13:11,960
occurs as a rare complication of renal disorders
172
00:13:11,960 --> 00:13:16,380
ุฒูŠ polycystic kidney, chronic lumbar nephritis,
173
00:13:16,600 --> 00:13:24,310
hydronephrosis, renal tumor An extrarenal tumor ุฒูŠ
174
00:13:24,310 --> 00:13:27,910
ุงู„ู‡ูŠุจุงูŠุชูˆู…ุง ูˆุงู„ุจุฑูˆู†ูƒูŠู„ ูƒุงุฑุณูŠู†ูˆู…ุง ูƒู„ู‡ุง ุนุจุงุฑุฉ ุนู†
175
00:13:27,910 --> 00:13:34,430
ุญุงู„ุงุช ู…ุฑุถูŠุฉ ุจุชุฎู„ู‚ ุงู„ูˆุงุญุฏ ุงู„ู…ุฑูŠุถ to release the
176
00:13:34,430 --> 00:13:38,370
erythropoietin inappropriately ู‡ุงูŠ ุงู„ู€ secondary
177
00:13:38,370 --> 00:13:41,290
polycythemia ุจุฑุถู‡ ุญุงู„ุงุช ู…ุฑุถูŠุฉ ุฒูŠ ุงู„ู€ arterial blood
178
00:13:41,290 --> 00:13:48,690
gas ุนุดุงู† ุชุดุฎุต ุงู„ู€ secondary polycythemia ุจุฏูƒ ุชุนู…ู„
179
00:13:48,690 --> 00:13:54,410
ุงู„ูุญูˆุตุงุช ุงู„ุชุงู„ูŠุฉ: ู†ู…ุฑุฉ ูˆุงุญุฏ arterial blood gasุŒ ู†ู…ุฑุฉ
180
00:13:54,410 --> 00:13:58,550
ุงุซู†ูŠู† hemoglobin electrophoresisุŒ ู†ู…ุฑุฉ ุซู„ุงุซุฉ oxygen
181
00:13:58,550 --> 00:14:03,050
dissociation curveุŒ ู†ู…ุฑุฉ ุฃุฑุจุนุฉ erythropoietin level
182
00:14:03,050 --> 00:14:08,990
ุฎู…ุณุฉ ultrasound abdomen and chest x-rayุŒ ุจุนุฏูŠู†
183
00:14:08,990 --> 00:14:15,340
total red blood cell volume ุชุดูˆููˆุง ุซุงุจุช ูˆู„ุง ู„ุฃ by labeling
184
00:14:15,340 --> 00:14:20,820
the RBCs by Chromium 51 ูˆู‡ูŠ Total Plasma Volume
185
00:14:20,820 --> 00:14:27,540
ุฃูŠุถุงู‹ by labeling by Iodine 125 ู…ุฑุชุจุท
186
00:14:27,540 --> 00:14:31,360
ุจุงู„ุฃู„ุจูˆู…ูŠู†
187
00:14:31,360 --> 00:14:36,320
ุงู„ู€
188
00:14:36,320 --> 00:14:40,480
Appropriate Polycythemia rather than defined as
189
00:14:40,480 --> 00:14:40,720
those
190
00:15:01,850 --> 00:15:06,930
ุฃูˆ ุจุงุณุชุฎุฏุงู… ู…ุฌู…ูˆุนุงุช ุงู„ุฑุณู…ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ
191
00:15:06,930 --> 00:15:10,910
ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ
192
00:15:10,910 --> 00:15:10,990
ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ
193
00:15:10,990 --> 00:15:12,490
ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉ ุงู„ุฑูˆุญุงู†ูŠุฉูˆ
194
00:15:12,490 --> 00:15:16,730
ุงู„ู€ PCV towards the lower limit of normality ูŠุนู†ูŠ
195
00:15:16,730 --> 00:15:20,830
ู‡ุฐุง ูŠุตู„ ุฅู„ู‰ ุงู„ู€ lower limit ุงู„ู„ูŠ ู…ุง ุชู‚ุฑูŠุช ูˆู‡ุฐุง
196
00:15:20,830 --> 00:15:25,830
ูŠุตู„ ู„ุจู„ุงุฒู…ุง ุฅู„ู‰ ุงู„ู€ upper limit of ash of ุจู„ุงุฒู…ุง
197
00:15:25,830 --> 00:15:29,210
ุฅุฌุฑุงุก ุงู„ู€ Polycythemia is by far the most common
198
00:15:29,210 --> 00:15:36,650
finding where ุงู„ู€ PCV is only minimally increased ูˆ
199
00:15:36,650 --> 00:15:41,730
ุจุดูƒู„ ู‚ู„ูŠู„ ูŠูƒูˆู† ุฃูˆ ุจูŠุตู„ ู„ุบุงูŠุฉ ุฎู…ุณูŠู† ููŠ ุงู„ู…ุงุฆุฉ of such
200
00:15:41,730 --> 00:15:45,550
cases alternative names of this condition include
201
00:15:45,550 --> 00:15:47,990
relative polycythemia, stress polycythemia,
202
00:15:48,110 --> 00:15:53,250
stressed polycythemia and spurious polycythemia
203
00:15:55,850 --> 00:16:03,710
ุงู„ู€ Causes stress, cigarette smoking, alcohol intake,
204
00:16:03,710 --> 00:16:09,530
ุงู„ู€ dehydration, ูˆ ุงู„ู€ plasma loss, ุฃูˆ ุงู„ู€ burn injury
205
00:16:09,530 --> 00:16:14,050
ูˆู‡ุฐุง ุงู„ุฌุฏูˆู„ ูŠุธู‡ุฑ ู„ู€ differential diagnosis of
206
00:16:14,050 --> 00:16:18,010
polycythemia which is summarized in this schedule
207
00:16:18,010 --> 00:16:22,090
ูƒู…ุง ุชุดุงู‡ุฏูˆู† ู‡ุฐุง ุงู„ู‚ุณู… ุงู„ุฃูˆู„ุงู†ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู†
208
00:16:22,090 --> 00:16:27,390
laboratory variables ุงู„ู„ูŠ ุจุฏู†ุง ู†ู‚ุงุฑู† ุจู‡ ู‡ู†ุง ุงู„ุซู„ุงุซ
209
00:16:27,390 --> 00:16:33,550
ุฃู†ูˆุงุน ุงู„ู€ Polycythemia: ุงู„ู€ primary, ุงู„ู€ secondary, ูุงู„ู€
210
00:16:33,550 --> 00:16:45,330
PCV is raised ููŠ ูƒู„ ุงู„ุซู„ุงุซ ู„ูƒู† ุงู„ู€ RBC ุจุฒูŠุฏ
211
00:16:45,330 --> 00:16:51,630
ููŠ ุงู„ู€ Primary Polycythemia normal ููŠ ุงู„ู€ aberrant ูˆููŠ ุฒูŠุงุฏุฉ ููŠ ุงู„ู€
212
00:16:51,630 --> 00:16:56,290
secondary polycythemia ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู†
213
00:16:56,290 --> 00:16:58,290
ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู†
214
00:16:58,290 --> 00:17:01,830
ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู†
215
00:17:01,830 --> 00:17:08,910
ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆ
216
00:17:08,910 --> 00:17:10,450
ุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆ
217
00:17:10,450 --> 00:17:11,130
ุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆ
218
00:17:11,130 --> 00:17:12,930
ุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆ
219
00:17:12,930 --> 00:17:15,510
ุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆ
220
00:17:15,510 --> 00:17:18,410
ุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆ
221
00:17:18,410 --> 00:17:22,990
ุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆุจูˆูŠุชูŠู† ุงู„ุฅุฑูŠุซุฑูˆ
222
00:17:22,990 --> 00:17:30,320
ุจูˆูŠุชูŠู† ุจุชุนู…ู„ ุจุฏู„ ุงู„ู€ body organsุŒ atrial
223
00:17:30,320 --> 00:17:33,400
spleen
224
00:17:33,400 --> 00:17:37,480
is enlarged ููŠ ุงู„ู€ Primary Polycythemia normal ููŠ ุงู„ุซุงู†ูŠุฉ atrial PO2
225
00:17:37,480 --> 00:17:41,660
normal ููŠ ุงู„ู€ Primary Polycythemia normal ููŠ ุงู„ู€ apparent or decrease
226
00:17:41,660 --> 00:17:46,500
or normal ููŠ ุงู„ู€ secondary 13 ุจู‚ู„ ููŠ ุงู„ู€ Primary Polycythemia
227
00:17:49,070 --> 00:17:59,510
ุงู„ุณูŠุฑุงุจ ุจูŠ ุชูˆู„ู ุฃูŠุถุงู‹ ูุฑู‚ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
228
00:17:59,510 --> 00:18:04,090
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
229
00:18:04,090 --> 00:18:05,070
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
230
00:18:05,070 --> 00:18:07,880
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุงู„ู…ุดูƒู„ุฉ
231
00:18:07,880 --> 00:18:16,820
ุงู„ู…ูˆุฌูˆุฏุฉ ููŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
232
00:18:16,820 --> 00:18:20,060
ุจูŠ
233
00:18:20,060 --> 00:18:20,820
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
234
00:18:20,820 --> 00:18:20,880
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
235
00:18:20,880 --> 00:18:20,960
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
236
00:18:20,960 --> 00:18:23,620
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
237
00:18:23,620 --> 00:18:29,320
ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ ุจูŠ
238
00:18:29,320 --> 00:18:36,930
ุจูŠ ุจู…ุดูƒู„ุฉ ุนุงู…ุฉ ูŠุดูƒูˆ ุงู„ู…ุฑูŠุถ ุงู„ู„ูŠ ุนู†ุฏู‡ ุจูˆู„ูŠุณุง ุซูŠู…ูŠุง
239
00:18:36,930 --> 00:18:44,730
ูˆ ุจู„ูˆ ู‡ุฏูƒ ูˆ blurred visionุŒ ุฒุบู„ู„ุฉ ุซู… dizziness ุฏูˆุฎุฉ
240
00:18:44,730 --> 00:18:49,390
ุซู… mental impairmentุŒ ุนุฏู… ุชุฑูƒูŠุฒ ุซู… feeling of
241
00:18:49,390 --> 00:18:54,390
congestion on the headุŒ ุฃูŠุถุงู‹
242
00:18:54,390 --> 00:18:59,270
ุจูŠุนุงู†ูŠ ู…ู† splenomegalyุŒ ู„ุฃู†ู‡ ููŠู‡ ุฒูŠุงุฏุฉ ู…ู„ุญูˆุธุฉ ููŠ ุงู„ู‡ูŠู…ูˆุฌู„ูˆุจูŠู†
243
00:19:00,730 --> 00:19:03,490
ูˆุงู„ู€ hyperviscosityุŒ ูˆ ุงู„ู€ impairment of blood flow
244
00:19:03,490 --> 00:19:07,890
ุจุชุณุงู‡ู… ููŠ ุฒูŠุงุฏุฉ ุงู„ู€ incidence of arterial and
245
00:19:07,890 --> 00:19:13,110
venous thrombosisุŒ ุนุดุงู† ู‡ูŠูƒ ููŠ ู„ู‡ุง ุนู„ุงุฌ ู„ุงุฒู… ุชุงุฎุฐู‡
246
00:19:13,110 --> 00:19:18,230
ูŠุนู†ูŠ ุฃู‚ู„ ู…ู† ุงู„ู€ plateletุŒ ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ baby aspirin
247
00:19:18,230 --> 00:19:23,370
ุซู… ุงู„ู€ platelet dysfunctionุŒ ู‡ูˆ ุชู†ุฏู†ุณูŠ to bruiseุŒ a
248
00:19:23,370 --> 00:19:28,170
bleeding ุชู†ุฏู†ุณูŠ ู…ูˆุฌูˆุฏุฉ ู„ูƒู† ู…ุด ุดุบุงู„ุฉุŒ ุซู… ุงู„ู€ severe
249
00:19:28,170 --> 00:19:35,670
itching ููŠ ุญูƒุฉ ูุธูŠุนุฉ particularly ุจุนุฏ warm bath
250
00:19:35,670 --> 00:19:42,530
ูˆู‡ุฐุง ู†ุชุฌ ุนู† ุงู„ู‡ุณุชุงู…ูŠู†
251
00:19:42,530 --> 00:19:48,030
ุงู„ุฐูŠ ุชู… ุฅุทู„ุงู‚ู‡ ู…ู† ุงู„ุจูŠุฒูˆููŠู„ุŒ ูŠูˆุฌุฏ ุฅุชุดูŠู†ุบ ุฎุตูˆุตุงู‹ ุจุนุฏ
252
00:19:48,030 --> 00:19:53,090
ุญู…ุงู… ุณุงุฎู† ู„ุฃู† ู‡ู†ุงูƒ ุฒูŠุงุฏุฉ ููŠ ุฅูุฑุงุฒ ุงู„ู‡ุณุชุงู…ูŠู† ู…ู†
253
00:19:53,090 --> 00:19:57,670
ุงู„ุจูŠุฒูˆููŠู„ ุนุจุงุฑุฉ ุนู† ุงู„ู€ findingsุŒ ู†ุฌุฏ ูƒุฑูŠุณูŠ ู…ุฌู„ูˆ ุจูŠู†
254
00:19:57,670 --> 00:20:02,780
PCV ูˆ RBC ุฒูŠุงุฏุฉ ููŠ ุงู„ู€ granulocyte, neutrophil
255
00:20:02,780 --> 00:20:05,920
morphology and function are increasedุŒ platelet
256
00:20:05,920 --> 00:20:11,120
increases ู„ูƒู† ุฎู…ุณูŠู† ููŠ ุงู„ู…ุงุฆุฉ by bizarre shape ูˆ
257
00:20:11,120 --> 00:20:15,980
.. ูˆ .. ุฎู…ุณ .. platelet increase by about fifty
258
00:20:15,980 --> 00:20:22,580
percent ูˆ ุงู„ุฃุดูƒุงู„ ุบูŠุฑ ุงู„ุทุจูŠุนูŠุฉ ุฒูŠ ุงู„ู€ bizarre shape
259
00:20:22,580 --> 00:20:25,760
platelet morphology and dysfunction ู‡ุฐุง ุดูŠุก common
260
00:20:25,760 --> 00:20:31,100
common with hypercellular bone marrow ุฃูˆ over
261
00:20:31,100 --> 00:20:36,320
granulocytes ูˆ ุงู„ุงุฑุชุฑูˆุฏ ู‡ูŠ paraplegia is less
262
00:20:36,320 --> 00:20:41,080
common cytogenetic abnormality ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ูŠุนู†ูŠ
263
00:20:41,080 --> 00:20:48,860
ู…ูˆุฌูˆุฏุฉ ููŠ 15% ู…ู† ุญุงู„ุงุช ุงู„ู€ .. ุจุงู„ุญุงู„ุงุช presentation
264
00:20:51,550 --> 00:20:54,030
ู‡ุฐู‡ ุงู„ุชุญู‚ูŠู‚ุงุช ุงู„ุจุฑู†ุงู…ุฌูŠุฉ Normal, neutrophil,
265
00:20:54,090 --> 00:20:58,790
alkaline phosphatase, plasma urate, circulating
266
00:20:59,910 --> 00:21:07,530
erythroid precursors, low serum erythropoietin
267
00:21:07,530 --> 00:21:10,670
clinical
268
00:21:10,670 --> 00:21:13,950
features, majority of patient ุจูŠุนุงู†ูˆุง ู…ู† ุงู„ุฃูˆุฑุฏุฉ
269
00:21:13,950 --> 00:21:18,910
thrombosis ุจู…ุง ููŠู‡ุง ุงู„ู€ portal ansplenic vein
270
00:21:20,710 --> 00:21:27,930
ู‡ูŠ DVT ูˆ DV ู†ุชhrombosis ูˆู‡ูŠุจุฑุชู†ุดู† ู‡ูŠุฏูŠูƒ ูˆ poor
271
00:21:27,930 --> 00:21:33,630
vision and dizzinessุŒ skin
272
00:21:33,630 --> 00:21:38,730
complications ุจู…ุง ููŠู‡ุง ุงู„ู€ pruritus ูˆ ุงู„ู€ erythromelalgia
273
00:21:38,730 --> 00:21:45,550
could be ูˆ ุงู„ู€ hemorrhage GIT due to platelet defect
274
00:21:45,550 --> 00:21:48,750
ูˆู‡ูŠ
275
00:21:48,750 --> 00:21:50,090
ุงู„ู€ erythromelalgia
276
00:21:51,960 --> 00:21:57,640
ุงู„ุญู…ุงุฑ ุงู„ู„ูŠุจูŠ ูˆุดูƒู„ ุทุจุนุงู‹ ููŠู‡ ุจุชูˆุณุจูŠู† ูˆู…ูŠุฌุง ูƒุงุฑูŠูˆุณูŠุชุณ ุฒูŠ ู…ุง
277
00:21:57,640 --> 00:22:01,360
ุฃู†ุชูˆุง ุดุงูŠููŠู†ุŒ liver ุนุงู„ูŠ ูˆุงู„ุณุณุจู„ูŠู† ุนุงู„ูŠ
278
00:22:01,360 --> 00:22:08,920
ุงู„ู€ erythromelalgia have increased skin temperature and
279
00:22:08,920 --> 00:22:16,580
burning sensation or redness 25% ู…ู† ุงู„ุญุงู„ุงุช ุชุฌู„ุจ
280
00:22:16,580 --> 00:22:20,880
ู„ู€ Chronic Myelofibrosis ูˆุทูˆู„ ุงู„ุญุงู„ุงุช ุชุฌู„ุจ ู„ู€ Acute
281
00:22:20,880 --> 00:22:28,360
Lymphoid Lymphoplastic Leukemia ูˆุบุงู„ุจุงู‹ ุงู„ุชุนุงู…ู„
282
00:22:28,360 --> 00:22:37,300
ุจุงู„ูƒูŠู…ูˆุชุฑุงุจูŠ ุงู„ู„ูŠ ู…ุฑุชุจุท ุจุงู„ุชุบูŠูŠุฑ ู„ู€ ANLL ุงู„ู’ู…ูุนุงู…ู„ุฉ
283
00:22:37,300 --> 00:22:42,770
ุงู„ุชุนุงู…ู„ูŠุฉ ุงู„ุฑุฆูŠุณูŠุฉ ู‡ูŠ ุชู‚ู„ูŠุฏ ุงู„ุชุนุงู…ู„ ุงู„ุฑูˆุจูˆุชูŠูƒูŠ ุนุดุงู†
284
00:22:42,770 --> 00:22:44,970
ุชู‚ู„ู„ ู…ู† ุงู„ู€ Thrombotic Complication ุจูŠุนู…ู„ูˆุง
285
00:22:44,970 --> 00:22:51,390
Debulking ุจูŠุดูŠู„ูˆุง RBCs by removal of RBCs and
286
00:22:51,390 --> 00:22:56,230
platelets ูˆู‡ุฐู‡ ุงู„ุนู…ู„ูŠุฉ ุจุชุชู… by Aphoresis or by
287
00:22:56,230 --> 00:23:01,650
repeated clonal proliferation median survival time
288
00:23:01,650 --> 00:23:06,630
ุจูŠูˆุตู„ 15 ุณู†ุฉ ูˆููŠ additional treatment may not be
289
00:23:06,630 --> 00:23:11,970
needed because it's controversial ุฒูŠ ุงู„ูƒูŠู…ูˆุซูŠุฑุงุจูŠ
290
00:23:15,860 --> 00:23:17,260
ุฒูŠ ุงู„ุนู„ุงุฌ